Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
In August, the U.S. Citizenship and Immigration Services eliminated the deferred action program, a step that will lead to the deportation of immigrants being treated in the U.S. for serious medical conditions. This cruel and inhumane policy will cut off access to lifesaving treatment for many patients in need, including cancer patients being treated here at Dana-Farber.
Last week, we stood with local leaders to speak out against this policy at an event led by the Irish International Immigrant Center (IIIC). Dana-Farber has worked closely with IIIC for over a decade as they have provided substantial pro bono legal support to some of our pediatric patient families. In the month remaining before the deportations begin, we will continue working with IIIC and others to identify resources for patients and families so they can maintain the care their life depends on. We will share additional details with all of you as these efforts develop.
As I’ve said before, Dana-Farber is above all a place of hope and healing, and we will continue to strive to provide the best possible care and support to all of our patients and families.
Laurie H. Glimcher, MD
President and CEO
Dana-Farber Cancer Institute
Posted on September 04, 2019
Media Contacts
For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to media@dfci.harvard.edu.